Timolol Clinical Trials Timolol RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema
Condition:   Diabetic Macular Edema Interventions:   Drug: Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide;   Drug: Injections of 1.25 mg of intravitreal bevacizumab with artificial tears Sponsor:   Shahid Beheshti University of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2021 Category: Research Source Type: clinical trials